FDA NDC Directory · JSON-LD · Markdown

Naproxen Sodium

NDC 59726-751 · HUMAN OTC DRUG · CAPSULE

Labeler / ManufacturerP & L Development, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA202807
Dosage form / routeCAPSULE · ORAL
Active ingredientsNAPROXEN SODIUM (220 mg/1)
Marketing started20201204
Marketing ended20261231
Package count1

External sources

Source: openFDA. Public-domain (CC0).